Microbicide research in developing countries: Have we given the ethical concerns due consideration?

BMC Medical Ethics

Volumn 8, Issue , 2007, Pages

  Moodley, Keymanthri ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE SULFATE; MICROBICIDE; NONOXINOL 9; PLACEBO; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELLULOSE; DRUG DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NONOXINOL;

CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; LEGAL ASPECT; MEDICAL ETHICS; METHODOLOGY; PARENTAL CONSENT; PATIENT SAFETY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY RATE; RESEARCH ETHICS; RESPONSIBILITY; REVIEW; RISK BENEFIT ANALYSIS; SCIENTIFIC LITERATURE; SEROCONVERSION; SEXUALITY; SOCIAL PSYCHOLOGY; SOUTH AFRICA; VAGINAL BRUISING; VAGINAL PRURITUS; VAGINAL ULCER; ADOLESCENT; ARTICLE; CONDOM; DISEASE TRANSMISSION; ETHICS; FEMALE; HEALTH CARE DELIVERY; MALE; MEDICAL RESEARCH; MORALITY; PERSONNEL; PHASE 3 CLINICAL TRIAL; PREGNANCY COMPLICATION; PROFESSIONAL STANDARD; RESEARCH SUBJECT; RISK ASSESSMENT; UTILIZATION REVIEW; VIROLOGY; VULNERABLE POPULATION;

ADOLESCENT; AIDS VACCINES; ANTI-HIV AGENTS; BIOMEDICAL RESEARCH; CELLULOSE; CLINICAL TRIALS, PHASE III AS TOPIC; CONDOMS; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFORMED CONSENT; MALE; MORAL OBLIGATIONS; NONOXYNOL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUBJECTS; RISK ASSESSMENT; SEXUAL PARTNERS; SOUTH AFRICA; VULNERABLE POPULATIONS;

EID: 36348951983     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-8-10     Document Type: Review

References (41)

1. The ethics of clinical research in the third world. M Angell, N Engl J Med 1997 337 847 9 10.1056/NEJM199709183371209 9295243
2. The Highest Attainable Standard: Ethical Issues in AIDS Vaccines. BR Bloom, Science 1998 279 186 188 10.1126/science.279.5348.186 9446225
3. HIV Vaccine Trial Participation in South Africa: An ethical assessment. K Moodley, J Med & Phil 2002 27 197 215 10.1076/jmep.27.2.197.2986
4. Ethical Considerations in HIV Preventive Vaccine Research. UNAIDS, 2002
5. A Conntrolled Trial of Nonoxynol 9 Film to Reduce Male-to-female Transmission of Sexually Transmitted Diseases. RE Roddy L Zekeng KA Ryan U Tamoufe SS Weir EL Wong, N Eng J Med 1998 339 504 510 10.1056/ NEJM199808203390803
6. Effectiveness of COL- a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. L Van Damme G Ramjee M Alary Vuylsteke V Chandeying H Rees P Sirivongrangson L Mukenge-Tshibaka V Ettiegne-Traore C Uaheowitchai SS Abdool Karrim B Masse J Perriens M Laga, The Lancet 1492 360 971 977 10.1016/S0140-6736(02)11079-8
7. Cellulose sulphate microbicide trial halted. J Horwood, The Lancet Infectious Diseases 2007 7 183 10.1016/S1473-3099(07)70039-7 17330365
8. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. CJ Elias C Coggins F Alvarez V Brache IS Fraser M Lacarra P Lahteenmaki R Massai DR Mishell DM Phillips AM Salvatierra, Contraception 1997 56 387 389 10.1016/S0010-7824(97)00176-5 9494773
9. A randomized phase 1 vaginal safety study of three concentrations of C31G vs. extra strength Gynol II. CK Mauck DH Weiner MD Creinin KT Barnhart MM Callahan R Bax, Contraception 2000 70 233 240 10.1016/j.contraception.2004.04. 010
10. Safety and Tolerability of Buffergel, a Novel Vaginal Microbicide, in Women in the United States. KH Mayer J Peipert T Fleming A Fullem T Moench S Cu-Uvin M Bentley M Chesney Z Rosenberg, Clin Infect Dis 2001 31 476 482 10.1086/318496
11. Phase 1 trial of the Topical Microbicide BufferGel: Safety Results from Four International Sites. J Van de Wijgert A Fullem C Kelly S Mehendale S Rogpao N Kumwenda Z Chirenje S Joshi T Taha N Padian R Bollinger K Nelson, J Acquir Immune Defic Syndr 2001 26 21 27 11176265
12. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. KH Mayer SA Karim C Kelly L Maslankowski H Rees AT Profy for the HIV Prevention Trials Network (HPTN) 020 Protocol Team, AIDS 2003 17 321 329 10.1097/00002030-200302140-00005 12556685
13. Council for International Organizations of Medical Sciences (CIOMS) 1993 International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva
14. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. KH Mayer LA Maslankowski F Gai WM El-Sadr J Justman A Kwiecien B Masse JF Rooney Soto-Torres L and the HPTN 050 Protocol Team, AIDS 2006 20 543 551 10.1097/01.aids.0000210608.70762.c3 16470118
15. Men's attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. JH Van de Wijgert GN Khumalo-Sakutukwa C Cogins SE Dube P Nyamapfeni N Padian, International Family Planning Perspectives 1999 25 15 20 10.2307/2991897
16. The Acceptability of a Vaginal Microbicide Among South African Men. G Ramgee E Gouws A Andrews L Myer AE Weber, International Family PlanningPerspectives 2001 27 4 164 170 10.2307/2673851
17. Acceptability of vaginal microbicide among Nigerian serodiscordant couples with female negative partner. D Onwujekwe N Odunukwe O Njemanze P Ezeobi T Gbajabiamila R Adu B Akinbami R Audu O Idigbe, Conference Proceedings Microbicides 2006 Conference Cape Town South Africa 23-26 April 2006
18. Acceptability of using a vaginal gel before sex in Umkanyakude District of KwaZulu Natal. M Mzimela, Conference Proceedings Microbicides 2006 Conference Cape Town South Africa 23-26 April 2006
19. Challenges to microbicide introduction in South Africa. P Orner J Harries D Cooper J Moodley M Hoffman J Becker E McGrory R Dabash H Bracken, Social Science and Medicine 2006 63 968 978 10.1016/j.socscimed.2006.02.019
20. Female control of sexuality: Illusion or reality? Use of vaginal products in southwest Uganda. G Green R Pool S Harrison GJ Hart J Wilkinson S Nyanzi JAG Whitworth, Social Science and Medicine 2001 52 585 598 10.1016/S0277-9536(00) 00162-3
21. A study of women's preferences regarding the formulation of over-the-counter vaginal spermicides. C Coggins C Elias R Atisook MT Basset V Ettiegne-Traore PD Ghys L Jenkins-Woelk E Thongkrajai NL Van Devanter, AIDS 1998 12 1389 1391 10.1097/00002030-199811000-00022 9708420
22. Women's interest in vaginal microbicides. JE Darroch J Frost, Family Planning Perspectives 1999 31 16 23 10.2307/2991552 10029928
23. Covert Use of a Vaginal Microbicide: Views of Women Participating in a Phase 1 Trial of Tenofovir Gel (HPTN 050). S Hofman, Conference Proceedings Microbicides 2006 Conference Cape Town South Africa 23-26 April 2006
24. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. M Schwandt C Morris A Ferguson Ngugi S Moses, Sexually Transmitted Infections 2006 82 392 396 10.1136/sti.2006.019794 16790563
25. Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. I De Zoysa CJ Elias ME Bentley, Am J Public Health 1998 88 571 575 9550996
26. The ethics of testing microbicides: are we protecting the volunteers or the investigators? M Potts, AIDS 2001 15 49 53 10.1097/00002030-200102001-00075
27. HIV prevention and global inequality: steps toward improved standards of care. K Shapiro SR Benatar, J Med Ethics 2005 31 39 49 10.1136/jme.2004.008102 15634752
28. Safety Considerations in Microbicide Trials: FDA Perspective. D Birnkrant, Conference Proceedings HPTN Microbicide Safety Consensus Meeting, Bethesda, 1-3 March 2006
29. Guidelines on reproductive heath research and partners'agreement. World Health Organisation (WHO) Scientific and Ethical Review Group
30. Ethical issues related to pregnancy during microbicide trials. E Tolley, Conference Proceedings Microbicides 2006 Conference Cape Town South Africa 23-26 April 2006
31. Microbicides 2006: High rates of pregnancy pose challenges for microbicide trials. T Smart, http://www.aidsmap.com/en/news/3F76DCE3-83FA-4523- A920-5CB0829DD33A.asp
32. Issues related to pregnancies in microbicide effectiveness trials. E Raymond, Microbicides 2006 Conference, Cape Town, OB15 2006
33. Change in sexual behavior post-pregnancy in the Savvy Ghana trial. W Rountree, Microbicides 2006 Conference, Cape Town, OB17 2006
34. The impact of pregnancy on microbicide clinical trials. CA Schreiber, Microbicides 2006 Conference, Cape Town, PB67 2006
35. Informed Consent for HIV Testing in a South African Hospital: Is It Truly Informed and Truly Voluntary? Q Abdool Karim SS Abdool Karim HM Coovadia M Susser, American J of Public Health 1998 88 4 637 40
36. Consent for Participation in the Bloemfontein Vitamin a Trial: How Informed and Voluntary? G Joubert H Steinberg E van der Ryst P Chikobvu, American J of Public Health 2003 93 4 582 84
37. Informed Consent: Participants' Knowledge and Perceptions of Influenza Vaccine Trial Involvement in South Africa. K Moodley M Pather L Myer, JME 2005 31 727 732
38. South African Parliament, Child Care Act No 74 of 1983
39. South African Parliament, Children's Act No 38 of 2005
40. South African Parliament, National Health Act No 61 of 2003
41. Girls bunk school to cash in on HIV trials. P Govender, Sunday Times 2005